Summary & Overview
HCPCS Level II E1632: Wearable Artificial Kidney, Each
HCPCS Level II code E1632 designates a wearable artificial kidney device intended for ambulatory or home-based renal replacement therapy. As wearable dialysis technology advances, E1632 has national relevance for device procurement, outpatient care models, and coverage policy for durable medical equipment. The code captures a novel class of renal replacement devices that may shift some dialysis care from in-center to wearable or home-managed settings.
Key payers included in national analyses are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for wearable renal replacement, coverage considerations by major payers, and benchmarking areas such as utilization, coding practice, and reimbursement policy. The publication highlights areas where payers may issue local coverage determinations, the potential billing pathways for device acquisition versus rental, and operational implications for outpatient dialysis providers and home health programs.
This summary provides a concise reference for payers, provider billing teams, and health policy analysts seeking to understand the role of HCPCS Level II code E1632 in the evolving landscape of renal replacement therapy and durable medical equipment coverage.
Billing Code Overview
HCPCS Level II code E1632 describes a wearable artificial kidney, each. This HCPCS code represents a durable medical device designed to provide continuous or ambulatory renal replacement therapy in a wearable format.
Service type: Durable medical equipment / renal replacement device
Typical site of service: Outpatient ambulatory settings or patient-managed home use where wearable dialysis is provided
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A wearable artificial kidney (E1632) is provided to an adult patient with end-stage renal disease (ESRD) who requires continuous or extended-duration renal replacement therapy outside of an inpatient dialysis unit. Typical patient: a 58-year-old patient with ESRD secondary to diabetic nephropathy who has been assessed by a nephrology team and qualifies for ambulatory, wearable dialysis to allow increased mobility and home-based therapy. Clinical workflow: nephrology evaluates candidacy, prescribes the wearable artificial kidney and necessary consumables, and arranges device education with a dialysis nurse and biomedical technician. Patient training includes device setup, vascular access handling (AV fistula or graft care, or tunneled catheter precautions), anticoagulation monitoring, infection prevention, troubleshooting alarms, and emergency procedures. Prior to first dispensing, the clinic documents indications, reviews prior dialysis adequacy (Kt/V or urea reduction ratio), vascular access status, and completes benefit verification with the payer. Device fitting and initial activation typically occur in an outpatient dialysis center or specialty clinic with observation for hemodynamic stability, then transition to home with periodic in-clinic assessments and remote monitoring for therapy efficacy and complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to provide the device involves substantially greater effort or time than usual (document justification). |